राष्ट्रिय क्षयरोग कार्यक्रमले सबै अनुसन्धानहरुको लागि पहिचान गरेका दुइ उद्देश्यहरु निम्न छन्

  • देशभर रहेका क्षयरोग संक्रमितहरुको हेरचाहको गुणस्तरमा सुधार
  • क्षयरोग कार्यक्रमको प्रभावकारी योजना र कार्यन्वयनमा योगदान

चालु अनुसन्धानहरुमा

  • नेपाल संस्थागत DOTS सम्भव नभएका ग्रामिण पहाडी जिल्लाहरुमा परिवार तथा समुदाय स्वयंसेवकमा आधारित अनुसन्धान चालु अवस्थामा रहेको छ
  • सबै संक्रमितहरुमा उच्च गुणस्तरको सेवा प्राप्ति र सो को नतिजा उपयुक्त तवरमा संकलन र अभिलेख सुनिश्चित गर्न निजि चिकित्सकहरुले दिने सेवा/सुविधा र सम्बन्धित विरामीको विवरण समेत राष्ट्रिय क्षयरोग कार्यक्रममा समावेशगर्नको लागि अनुसन्धान जारि छ

Drug Resistance Tuberculosis: Treatment of TB with DOTS is highly effective, if patients take the proper dose of medicines regularly. But irregularity and wrong dose of taking medicines, results in resistant to drugs. The NTP has carried out frequent surveys of drug resistance both in central as well as in periphery level. The latest survey conducted in 2001/2002 showed multi drug resistance (MDR) of 1.30% compared to 3.60% in 1998/1999 and 1.20% in 1996/1997. The latest survey shows that Multi- Drug Resistant (MDR) TB is decreasing in newly registered cases and it is a sign of good DOTS programme. NTP also completed the latest cluster sample survey in 2006, results will be published by early 2007. HIV/AIDS and Tuberculosis: The prevalence of HIV is raising in Nepal and effective control measures for AIDS as well as for TB is more important now than ever before. NTP is regularly surveys to detect how often HIV occurs in TB patients. In 2002, 2.4% of tuberculosis patients were infected with HIV. NTP also completed a sentinel site survey in 2006; results of this survey should be available by first quarter of 2007. Sustaining and further enhancing partnership remains one of the primary focus of the NTP. In this regard initiation of collaboration with National AIDS Programme (NAP) is one of the key achievements. A Core Group consisting members from NTP, NAP and other partners has been established which is aiming to facilitate the formation of a National TB HIV Collaboration Committee. Steps were also initiated to develop a joint collaboration strategy document by both programmes.